Fundraising Fox
Gene Solutions
Thailand, TH · 1 known investors
Find your way into Gene Solutions
Sign up to see every warm intro you have to Gene Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gene Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Gene Solutions is a biotechnology company that develops genetic testing solutions using Next-Generation Sequencing and artificial intelligence for reproductive health, clinical oncology, and multi-cancer screening. The company serves healthcare providers and patients seeking precision medicine through advanced genomic profiling and early cancer detection.
Founders & leadership
Board
Investors · 1
How we know: Mekong Capital's portfolio page · funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6M disclosed across 3 of 5 rounds · 2015–2025
▶$5.3MraisedJun 2024 · 12 investors · BiotechnologyRule 506(b)
- David B. PattesonExecutive Officer, Director
- James OuryDirector
- Edward P. ConnellExecutive Officer, Director
- Susan D. JonesExecutive Officer, Director
- Offering amount
- $5.3M
- Amount sold
- $5.3M
- First sale
- Dec 2018
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$65KraisedAug 2017 · 5 investors · BiotechnologyRule 506(b)
- Edward P. ConnellExecutive Officer, Director
- Brian WarringtonExecutive Officer, Director
- W. Davis Parker, Jr.Executive Officer, Director
- James OuryDirector
- Susan D. JonesExecutive Officer, Director
- David B. PattesonExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $65K
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$639.8KraisedOct 2015 · 2 investors · BiotechnologyRule 506(b)
- W. Davis Parker, Jr.Executive Officer, Director
- Brian WarringtonExecutive Officer, Director
- Edward P. ConnellExecutive Officer, Director
- James OuryDirector
- Susan D. JonesExecutive Officer, Director
- David B. PattesonExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $639.8K
- First sale
- Sep 2015
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Gene Solutions do?
- Gene Solutions is a biotechnology company that develops genetic testing solutions using Next-Generation Sequencing and artificial intelligence for reproductive health, clinical oncology, and multi-cancer screening. The company serves healthcare providers and patients seeking precision medicine through advanced genomic profiling and early cancer detection.
- Who are Gene Solutions's investors?
- Gene Solutions's investors include Mekong Capital.
- How much funding has Gene Solutions raised?
- Gene Solutions has disclosed $6M raised across 3 of its 5 known rounds.
- Where is Gene Solutions headquartered?
- Gene Solutions is headquartered in Thailand, TH.